ArticleActa pharmacologica Sinica2014

Telekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway.

Lin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.